11/29
01:34 am
obio
Analyst Confidence in Orchestra BioMed Holdings (OBIO) High Amid Key Clinical and Strategic Advancements [Yahoo! Finance]
Medium
Report
Analyst Confidence in Orchestra BioMed Holdings (OBIO) High Amid Key Clinical and Strategic Advancements [Yahoo! Finance]
11/26
05:38 pm
obio
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
11/26
04:05 pm
obio
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/13
09:01 am
obio
Orchestra BioMed (NASDAQ:OBIO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Medium
Report
Orchestra BioMed (NASDAQ:OBIO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
11/12
11:05 am
obio
Orchestra BioMed (NASDAQ:OBIO) had its price target lowered by analysts at Barclays PLC from $12.00 to $11.00. They now have an "overweight" rating on the stock.
Medium
Report
Orchestra BioMed (NASDAQ:OBIO) had its price target lowered by analysts at Barclays PLC from $12.00 to $11.00. They now have an "overweight" rating on the stock.
11/11
09:00 am
obio
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
Medium
Report
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
11/11
08:22 am
obio
What To Expect From Orchestra BioMed Holdings Inc (OBIO) Q3 2025 Earnings [Yahoo! Finance]
Medium
Report
What To Expect From Orchestra BioMed Holdings Inc (OBIO) Q3 2025 Earnings [Yahoo! Finance]
11/10
04:38 pm
obio
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates [Yahoo! Finance]
Medium
Report
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates [Yahoo! Finance]
11/10
04:10 pm
obio
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
Medium
Report
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
11/3
08:00 am
obio
Orchestra BioMed to Host Business Update Call on November 12, 2025
Low
Report
Orchestra BioMed to Host Business Update Call on November 12, 2025
10/28
08:00 am
obio
Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements
Medium
Report
Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements
10/27
09:00 am
obio
Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
Low
Report
Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
10/9
08:23 am
obio
Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit [Yahoo! Finance]
Low
Report
Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit [Yahoo! Finance]
10/9
08:00 am
obio
Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit
Low
Report
Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit